Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-07-24

Clinical Trial Update: Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment [Phase 2, Phase 3]

View source ↗

Summary

Multicenter withdrawal phase 2 and phase 3 trials are evaluating N-acetyl Glucosamine capsules for irritable bowel syndrome with diarrhea (IBS-D). The current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetyl Glucosamine Capsule (N-acetyl glucosamine)

Snippet

Sponsor: Third Military Medical University | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: UNKNOWN